glp-1 therapies success rates and mortality risk: Implications for life insurers Infographic: GLP 1 Adherence and

Davidson, R.J., Pizzagalli, D., Nitschke, J.B., Kalin, N.H

Pfizer is back in the game recently with its Metasera acquisition and associated portfolio of obesity therapeutics including two preclinical oral GLP-1 receptor agonists

GLP-1s are known to have positive cardiovascular effects, and better control of blood glucose levels through GLP-1 treatment has been shown to limit small blood vessel damage that can lead to health complications such as diabetic retinopathy

The cell's capacity to synthesise glutathione is described in the literature as determined not by any single amino acid in isolation but by the simultaneous availability of all three, in the right proportions, in the right cellular compartments, in the right metabolic state

These products are designed to help maintain muscle mass in individuals with reduced appetites, a common effect of GLP-1 drugs